MoneyWorks4Me

Lasa Supergenerics informs about closure of trading window

30 Sep 2024 Evaluate

Lasa Supergenerics has informed that as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives with effect from October 01, 2024 till 48 hours after the declaration of unaudited financial results (both days inclusive) for the quarter and half year ended September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..